Patients with aortic stenosis referred for TAVI: Treatment decision, in-hospital outcome and determinants of survival

Netherlands Heart Journal

Volumn 20, Issue 1, 2012, Pages 16-23

  Nuis, R J ^a   Dager, A E ^b   Van der Boon, R M ^a   Jaimes, M C ^c   Caicedo, B ^b   Fonseca, J ^b   Van Mieghem, N M ^a   Benitez, L M ^b   Umana, J P ^c,e   O'Neill, W W ^d   de Marchena, E ^d   de Jaegere, P P ^a,f  

^a Angiografia de Occidente SA   (Colombia)

^b Fundacion Clinica Cardio Infantil   (Colombia)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Aortic stenosis; Complications; Prognosis; Surgical aortic valve replacement; Transcatheter aortic valve implantation; Treatment decision

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART TAMPONADE; HEART VENTRICLE FIBRILLATION; HUMAN; KIDNEY FAILURE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT PREFERENCE; PATIENT REFERRAL; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PREDICTIVE VALUE; PROSPECTIVE STUDY; RATING SCALE; RETROPERITONEAL HEMORRHAGE; SHORT TERM SURVIVAL; STROKE; SUDDEN DEATH; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

EID: 84856247383     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0224-z     Document Type: Article

References (26)

1. Leon M, Smith C, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
2. Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9-13.
3. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2- isolated valve surgery. Ann Thorac Surg. 2009;88:S23-42.
4. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463-70.
5. Rosengart TK, Feldman T, Borger MA, et al. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2008;117:1750-67.
6. Serruys PW. Design of a novel randomized clinical trial comparing SAVR with TAVI in patients with severe aortic stenosis at intermediate peri-operative risk. Presented at TCT Congress September 21. Washington: 2010.
7. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-72.
8. Nuis RJ, van Mieghem NM, van der Boon RM, et al. Effect of experience on results of transcatheter aortic valve implantation using a medtronic corevalve system. Am J Cardiol. 2011;107:1824-9.
9. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J. 2007;28:230-68.
10. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
11. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-17.
12. Head SJ, Kappetein AP. Transcatheter aortic valve implantation after PARTNER: what is up next? EuroIntervention. 2010;6:560-1.
13. Rosenhek R, Iung B, Tornos P, et al. ESC Working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2011 epub ahead of print.
14. Piazza N, Wenaweser P, van Gameren M, et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system-a Bern-Rotterdam Study. Am Heart J. 2010;159:323-9.
15. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
16. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-90.
17. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve mplantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-7.
18. Lefevre T, Kappetein AP, Wolner E, et al. One year FU of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32:148-57.
19. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
20. Nuis RJ, Van Mieghem NM, Tzikas A, et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2011;77:881-9.
21. van Mieghem NM, Nuis RJ, Tzikas A, et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2011;7:184-91.
22. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention. 2010;5:666-72.
23. van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System(R): the Rotterdam experience. EuroIntervention. 2010;5:673-9.
24. Thielmann M, Wendt D, Eggebrecht H, et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thorac Surg. 2009;88:1468-74.
25. Roten L, Wenaweser P, Delacretaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010;106:1473-80.
26. Tzikas A, van Dalen BM, Van Mieghem NM, et al. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol. 2011;107:285-9.